OncoArendi Therapeutics Appoints Samson Fung, M.D. as Chief Medical Officer
- Thursday, January 27, 2022, 7:07
- Finance
- Add a comment
WARSAW, Poland, Jan. 27, 2022 /PRNewswire/ — OncoArendi Therapeutics S.A. (“OncoArendi”; WSE: OAT), a clinical stage biotechnology company that uses its world leading medicinal capabilities to discover and develop first in class small molecule drug candidates that directly modulate RNA…
About the Author
adminasapcorp has written 39670 stories on this site.